These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 36226253)

  • 1. Signaling pathways in the regulation of cancer stem cells and associated targeted therapy.
    Manni W; Min W
    MedComm (2020); 2022 Dec; 3(4):e176. PubMed ID: 36226253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling and targeting cancer stem cell signaling pathways for cancer therapeutics.
    Borlongan MC; Wang H
    Front Cell Dev Biol; 2023; 11():1125174. PubMed ID: 37305676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs.
    Zhao Q; Zong H; Zhu P; Su C; Tang W; Chen Z; Jin S
    Exp Hematol Oncol; 2024 Jan; 13(1):6. PubMed ID: 38254219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer stem cells and the challenges of eradication: a review of novel therapies.
    Saeg F; Anbalagan M
    Stem Cell Investig; 2018; 5():39. PubMed ID: 30498750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update.
    Clara JA; Monge C; Yang Y; Takebe N
    Nat Rev Clin Oncol; 2020 Apr; 17(4):204-232. PubMed ID: 31792354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting cancer stem cells in drug discovery: Current state and future perspectives.
    Du FY; Zhou QF; Sun WJ; Chen GL
    World J Stem Cells; 2019 Jul; 11(7):398-420. PubMed ID: 31396368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer stem cell mobilization and therapeutic targeting of the 5T4 oncofetal antigen.
    Harrop R; O'Neill E; Stern PL
    Ther Adv Vaccines Immunother; 2019; 7():2515135518821623. PubMed ID: 30719508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence.
    Aramini B; Masciale V; Grisendi G; Bertolini F; Maur M; Guaitoli G; Chrystel I; Morandi U; Stella F; Dominici M; Haider KH
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotargeting of Cancer Stem Cells.
    Köseer AS; Di Gaetano S; Arndt C; Bachmann M; Dubrovska A
    Cancers (Basel); 2023 Mar; 15(5):. PubMed ID: 36900399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on immune-based therapy strategies targeting cancer stem cells.
    Izadpanah A; Mohammadkhani N; Masoudnia M; Ghasemzad M; Saeedian A; Mehdizadeh H; Poorebrahim M; Ebrahimi M
    Cancer Med; 2023 Sep; 12(18):18960-18980. PubMed ID: 37698048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review).
    Katoh M
    Int J Oncol; 2017 Nov; 51(5):1357-1369. PubMed ID: 29048660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
    Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
    Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Informed by Cancer Stem Cells of Solid Tumors: Advances in Treatments Targeting Tumor-Promoting Factors and Pathways.
    MacLean MR; Walker OL; Arun RP; Fernando W; Marcato P
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Targeting of Cancer Stem Cells in Lung, Head and Neck, and Bladder Cancers.
    Mudra SE; Sadhukhan P; Ugurlu MT; Alam S; Hoque MO
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel therapeutic strategies for targeting liver cancer stem cells.
    Oishi N; Wang XW
    Int J Biol Sci; 2011 Apr; 7(5):517-35. PubMed ID: 21552419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Cancer Stem Cell Markers or Pathways: A Potential Therapeutic Strategy for Oral Cancer Treatment.
    Lee JW; Lee HY
    Int J Stem Cells; 2021 Nov; 14(4):386-399. PubMed ID: 34711702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting signaling pathways in cancer stem cells: A potential approach for developing novel anti-cancer therapeutics.
    Sinha S; Hembram KC; Chatterjee S
    Int Rev Cell Mol Biol; 2024; 385():157-209. PubMed ID: 38663959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
    Safa AR
    Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.